Biotechnology Stocks
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2496 |  IMMX Immix Biopharma, Inc. - Common Stock | 13.34 USD | -2.34% | +17.12% | +54.58% | +520.47% | 954.33 M USD | ||
| 2500 |  ARDX Ardelyx, Inc. - Common Stock | 3.80 USD | -2.31% | -6.63% | -25.93% | -38.11% | 946.91 M USD | ||
| 2515 |  CLYM Climb Bio, Inc. - Common Stock | 16.27 USD | -5.84% | -5.41% | +24.20% | +197.44% | 934.49 M USD | ||
| 2525 |  OLMA Olema Pharmaceuticals, Inc. - Common Stock | 10.55 USD | -1.31% | -2.76% | -11.94% | +28.82% | 923.10 M USD | ||
| 2533 |  IVA Inventiva S.A. - American Depository Shares | 4.64 USD | -0.85% | -1.28% | +4.50% | -2.73% | 896.62 M USD | ||
| 2544 |  TBPH Theravance Biopharma, Inc. - Ordinary Shares | 17.01 USD | 0.00% | +0.29% | +0.83% | +18.54% | 883.14 M USD | ||
| 2582 |  DBVT DBV Technologies S.A. - American Depositary Shares | 14.22 USD | -2.27% | -3.00% | +3.42% | +44.95% | 842.00 M USD | ||
| 2583 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 45.70 USD | -0.41% | +7.55% | +22.52% | +51.68% | 853.67 M USD | ||
| 2614 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 7.87 USD | -1.50% | +6.21% | +27.35% | +149.05% | 809.84 M USD | ||
| 2616 |  AURA Aura Biosciences, Inc. - Common Stock | 7.80 USD | 0.00% | +2.63% | +9.86% | +19.27% | 808.90 M USD | ||
| 2617 |  FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 14.49 USD | -8.46% | -2.49% | +41.78% | +28.23% | 800.49 M USD | ||
| 2624 |  PHAR Pharming Group N.V. - ADS, each representing 10 | 11.45 USD | -2.72% | -4.58% | -11.58% | -19.71% | 803.42 M USD | ||
| 2633 |  NVCT Nuvectis Pharma, Inc. - Common Stock | 24.20 USD | +2.72% | +26.70% | +24.94% | +251.23% | 788.47 M USD | ||
| 2637 |  STTK Shattuck Labs, Inc. - Common Stock | 7.83 USD | +3.98% | +6.39% | +6.24% | +741.94% | 785.84 M USD | ||
| 2661 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.72 USD | -2.75% | -1.03% | +11.81% | -18.64% | 749.35 M USD | ||
| 2662 |  NGNE Neurogene Inc. - Common Stock | 39.81 USD | +3.05% | +7.92% | +13.74% | +35.32% | 796.65 M USD | ||
| 2687 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.26 USD | +1.98% | +1.98% | +2.89% | +2.21% | 742.41 M USD | ||
| 2688 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 3.33 USD | +1.52% | -2.92% | +2.46% | +56.34% | 725.60 M USD | ||
| 2691 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 8.91 USD | +0.45% | -6.11% | -23.19% | -25.44% | 720.83 M USD | ||
| 2699 |  MNPR Monopar Therapeutics Inc. - Common Stock | 109.30 USD | +1.47% | -6.28% | -0.90% | +100.11% | 733.64 M USD |
뉴스 Biotechnology Stocks
2026년 8월 마지막 주 주목할 3개 토큰 언락
지난주 화제의 주식: 모더나, 스페이스X, 스트래티지, 브로드컴 및 월마트
데이터: H, HUMA, XPL 등 토큰이 다음 주 대규모 언락을 맞이할 예정이며, 이 중 H 언락 가치는 약 1990만 달러
우주 컴퓨팅 스타트업 Starcloud, 2억 5천만 달러 신규 투자 유치 완료... 엔비디아 참여
수요일 주목받은 주식: 모더나, 위불, 비트마인, 스트래티지 및 머크
Gate 계약 주식 전용관에 MRNA(모더나) 무기한 계약 거래 상장
머크·모더나가 쏜 훈풍···암 백신 대박에 바이오 ETF '들썩'
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.08 | +642.86% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0026 | +160.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.65 | +20.44% |
 APRE Aprea Therapeutics, Inc. - Common Stock | 0.75 | +17.19% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.81 | +16.77% |
 BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.1201 | +14.38% |
 CRDF Cardiff Oncology, Inc. - Common Stock | 1.00 | +13.64% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0045 | -50.00% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 7.84 | -26.87% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.09 | -18.17% |
 ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.14 | -16.19% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTXL BriaCell Therapeutics Corp. - Warrants | 0.9500 | -12.04% |